CellenGene Achieves US Patent Approval for Breakthrough CAR-T Therapy Targeting Solid Tumors
CellenGene Co., Ltd. (CEO Ahn Jae-hyung), a Korean drug development company, received approval for the US patent on "Receptor and ...
Tag: US Patent
Copyright © 2023 KoreaTechDesk | About Us
| Our Services| Terms of Use |Privacy Policy |Cookie Policy
Contact:
[email protected]
